Filter
2447
Filtered Results: 2447
Text search:
drug
regulation
Featured
Recommendations
193
New Publications
664
Language
Document type
No document type
1414
Studies & Reports
428
Guidelines
316
Manuals
123
Strategic & Response Plan
94
Fact sheets
23
Training Material
22
Situation Updates
14
Infographics
5
Brochures
4
Resource Platforms
4
Countries / Regions
India
109
Global
90
Kenya
86
Western and Central Europe
65
Nigeria
57
South Africa
55
Uganda
54
Ethiopia
51
Tanzania
45
Sierra Leone
43
Liberia
43
Ghana
42
Bangladesh
41
Africa
40
Latin America and the Carribbean
39
Nepal
38
Zambia
37
Malawi
33
Eastern Europe
30
Ukraine
28
Myanmar / Burma
28
Philippines
25
Rwanda
24
South–East Asia Region
24
Namibia
24
Indonesia
24
Zimbabwe
20
Asia
18
Lesotho
17
Cambodia
16
Russia
16
Syria
15
Botswana
15
Eswatini/ Swaziland
14
Congo, Democratic Republic of
11
Senegal
10
Pakistan
10
Mozambique
9
Venezuela
9
Thailand
8
Middle East and North Africa
8
Brazil
8
Georgia
8
Cameroon
7
Albania
7
USA
7
Haiti
7
Germany
7
Eastern Europe and Central Asia
7
Vietnam
7
Colombia
6
China
6
Burkina Faso
6
West and Central Africa
6
Laos
5
Western Pacific Region
5
East and Southern Africa
5
Sudan
5
Iraq
5
Tajikistan
4
El Salvador
4
Chile
4
Peru
4
Guinea
4
Argentina
4
Lebanon
4
Moldova
4
South Sudan
4
North Macedonia
3
Mexico
3
Turkey
3
Benin
3
Kyrgyzstan
3
Afghanistan
3
Jordan
3
Paraguay
3
Bolivia
3
Sri Lanka
3
Libya
3
Bhutan
3
Kazakhstan
2
Iran
2
Fiji
2
Uzbekistan
2
Morocco
2
Hungary
2
Portugal
2
Spain
2
Papua New Guinea
2
Yemen
2
Poland
2
Honduras
2
Somalia
2
Switzerland
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Singapore
1
Estonia
1
Mongolia
1
Qatar
1
Italy
1
Lithuania
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Belarus
1
Nicaragua
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Angola
1
Ecuador
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
970
Clinical Guidelines
164
Public Health
142
Women & Child Health
74
Key Resources
72
Pharmacy & Technologies
45
Capacity Building
21
Toolboxes
Mental Health
246
HIV
223
AMR
198
TB
162
Pharmacy
121
COVID-19
117
Rapid Response
59
NTDs
58
NCDs
53
Planetary Health
52
Caregiver
51
Ebola & Marburg
36
Global Health Education
33
Refugee
30
Conflict
30
Health Financing Toolbox
26
Disability
23
Specific Hazards
14
Polio
12
Zika
8
Natural Hazards
7
Social Ethics
7
Cholera
6
Malaria
1
There is an expanding market of no- and low-alcohol beverages (NoLos). However, their effects on global ethanol consumption and public health are still questioned. Policies and regulations about NoLos’ availability, acceptability and affordability are lacking and evidence about their benefits is l...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
Barbados currently has a rudimentary framework and capacity to address the issue of antimicrobial resistance. There however needs to be coordination of efforts and improvement in areas where gaps have been identified.Actions required include improved antibiotic stewardship in healthcare settings, pr...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
What are the FP and CAC competencies?
Through the clear articulation of the family planning and comprehensive abortion care (FP and CAC) competencies for the primary health care workforce, the aim is to advance improvements in FP and CAC service delivery by aligning health worker education approach...
This manual has been developed to guide rapid risk assessment of acute public health risks from any type of hazard in response to requests from Member States of the World Health Organization (WHO). The manual is aimed primarily at national departments with health-protection responsibilities, Nationa...
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions
expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to
describe the best treatments and pra...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Ghana's attempt to regulate health care waste management started in 2002 with the development of guidelines on health care waste manage-ment by the Environmental Protection Agency (EPA). In 2006, the Ghana Health Service (GHS) also developed the Health Care Waste Management Policy and Guidelines as ...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
Primary health care offers a cost–effective route to achieving universal health coverage (UHC). However, primary health-care systems are weak in many low- and middle-income countries and often fail to provide comprehensive, people-centred, integrated care. We analysed the primar...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
